| Drug General Information |
| Drug ID |
D0R4OM
|
| Former ID |
DAP000034
|
| Drug Name |
Trifluoperazine
|
| Synonyms |
Calmazine; Eskazine; Fluoperazine; Flurazine; Modalina; Stelazine; Stellazine; TFP; Trifluoperazin; Trifluoperazina; Trifluoperazinum; Trifluoromethylperazine; Trifluoroperazine; Trifluperazine; Triflurin; Trifluroperizine; Triftazin; Triftazine; Triperazine; Triphtazin; Triphtazine; Triphthasine; PMS Trifluoperazine; Stelazine Concentrate; Trifluoperazina [Italian]; Trifluoperazine HCl; Trifluoperazine dihydrochloride; Trifluoroperazine dihydrochloride; Tripfluoperazine Hydrochloride; NCI17474; RP 7623; SKF 5019; Apo-Trifluoperazine; Eskazine (TN); Eskazinyl (TN); Jatroneural (TN); Modalina (TN); Novo-Trifluzine; Stelazine (TN); Terfluzine (TN); Trifluoperaz (TN); Trifluoperazina [INN-Spanish]; Trifluoperazine (INN); Trifluoperazine [INN:BAN]; Trifluoperazinum [INN-Latin]; Apo-trifluoperazine (TN); Stelazine (*Dihydrochloride*); Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine; 10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine; 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine; 10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine; 10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE; 10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride; 2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
|
| Drug Type |
Small molecular drug
|
| Therapeutic Class |
Antipsychotic Agents
|
| Company |
GlaxoSmithKline plc
|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C21H24F3N3S
|
| InChI |
InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3
|
| InChIKey |
ZEWQUBUPAILYHI-UHFFFAOYSA-N
|
| CAS Number |
CAS 117-89-5
|
| PubChem Compound ID |
|
| PubChem Substance ID |
9377, 602753, 841996, 4252673, 5664287, 7890752, 7980830, 10319712, 10505141, 11110644, 11110645, 11120338, 11120826, 11121314, 11121780, 11122260, 11336018, 11361257, 11362944, 11363562, 11364843, 11365506, 11366124, 11367405, 11368068, 11368686, 11369967, 11371059, 11371060, 11372247, 11373007, 11373669, 11373974, 11375567, 11376230, 11376848, 11378135, 11405822, 11408478, 11458546, 11460495, 11462229, 11466341, 11467461, 11484491, 11486261, 11488644, 11491189, 11492183, 11494482
|
| ChEBI ID |
ChEBI:45951
|
| SuperDrug ATC ID |
N05AB06
|
| SuperDrug CAS ID |
cas=000117895
|
| Target and Pathway |
| References |
